Thüring C - Search Results

1

Neurofeedback for Tinnitus Treatment - Review and Current Concepts.

Güntensperger D, Thüring C, Meyer M, Neff P, Kleinjung T. Güntensperger D, et al. Among authors: thuring c. Front Aging Neurosci. 2017 Dec 1;9:386. doi: 10.3389/fnagi.2017.00386. eCollection 2017. Front Aging Neurosci. 2017. PMID: 29249959 Free PMC article. Review.

2

Investigating the Efficacy of an Individualized Alpha/Delta Neurofeedback Protocol in the Treatment of Chronic Tinnitus.

Güntensperger D, Thüring C, Kleinjung T, Neff P, Meyer M. Güntensperger D, et al. Among authors: thuring c. Neural Plast. 2019 Mar 26;2019:3540898. doi: 10.1155/2019/3540898. eCollection 2019. Neural Plast. 2019. PMID: 31049052 Free PMC article. Clinical Trial.

3

Combining neurofeedback with source estimation: Evaluation of an sLORETA neurofeedback protocol for chronic tinnitus treatment.

Güntensperger D, Kleinjung T, Neff P, Thüring C, Meyer M. Güntensperger D, et al. Among authors: thuring c. Restor Neurol Neurosci. 2020;38(4):283-299. doi: 10.3233/RNN-200992. Restor Neurol Neurosci. 2020. PMID: 32675432 Free PMC article.

4

[Neurofeedback for the treatment of chronic tinnitus : Review and future perspectives].

Kleinjung T, Thüring C, Güntensperger D, Neff P, Meyer M. Kleinjung T, et al. Among authors: thuring c. HNO. 2018 Mar;66(3):198-204. doi: 10.1007/s00106-017-0432-y. HNO. 2018. PMID: 29143096 Review. German.

5

SUV_max for predicting regional control in oropharyngeal cancer.

Lekanne Dit Deprez LW, Morand GB, Thüring C, Pazahr S, Hüllner MW, Broglie MA. Lekanne Dit Deprez LW, et al. Among authors: thuring c. Eur Arch Otorhinolaryngol. 2022 Jun;279(6):3167-3177. doi: 10.1007/s00405-021-07169-7. Epub 2021 Nov 15. Eur Arch Otorhinolaryngol. 2022. PMID: 34779928

6

HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma.

Thuring C, Follin E, Geironson L, Freyhult E, Junghans V, Harndahl M, Buus S, Paulsson KM. Thuring C, et al. Br J Cancer. 2015 Dec 1;113(11):1640. doi: 10.1038/bjc.2015.387. Br J Cancer. 2015. PMID: 26625215 Free PMC article. No abstract available.

7

HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma.

Thuring C, Follin E, Geironson L, Freyhult E, Junghans V, Harndahl M, Buus S, Paulsson KM. Thuring C, et al. Br J Cancer. 2015 Sep 15;113(6):952-62. doi: 10.1038/bjc.2015.297. Epub 2015 Aug 27. Br J Cancer. 2015. PMID: 26313662 Free PMC article.

8

HLA-I antigen presentation and tapasin influence immune responses against malignant brain tumors - considerations for successful immunotherapy.

Darabi A, Thuring C, Paulsson KM. Darabi A, et al. Among authors: thuring c. Anticancer Agents Med Chem. 2014;14(8):1094-100. doi: 10.2174/1871520614666140825110001. Anticancer Agents Med Chem. 2014. PMID: 25175689 Review.

9

Tapasin and human leukocyte antigen class I dysregulation correlates with survival in glioblastoma multiforme.

Thuring C, Geironson L, Paulsson K. Thuring C, et al. Anticancer Agents Med Chem. 2014;14(8):1101-9. doi: 10.2174/1871520614666140825110402. Anticancer Agents Med Chem. 2014. PMID: 25175688

10

Tapasin facilitation of natural HLA-A and -B allomorphs is strongly influenced by peptide length, depends on stability, and separates closely related allomorphs.

Geironson L, Thuring C, Harndahl M, Rasmussen M, Buus S, Røder G, Paulsson KM. Geironson L, et al. Among authors: thuring c. J Immunol. 2013 Oct 1;191(7):3939-47. doi: 10.4049/jimmunol.1201741. Epub 2013 Aug 26. J Immunol. 2013. PMID: 23980206

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page